(Q48137961)

9 February 2018

title

Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. (English)

1 reference

9 February 2018

0 references

0 references

Gaspar Reynés

1

1 reference

9 February 2018

Virtudes Vila

2

1 reference

9 February 2018

María Martín

3

1 reference

9 February 2018

Antonio Parada

4

1 reference

9 February 2018

Tania Fleitas

5

1 reference

9 February 2018

Edelmiro Reganon

6

1 reference

9 February 2018

Vicenta Martínez-Sales

7

1 reference

9 February 2018

publication date

6 July 2010

1 reference

9 February 2018

Journal of Neuro-Oncology

published in

1 reference

9 February 2018

volume

102

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

35-41

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-010-0290-x

exact match

0 references

cites work

Venous thromboembolism and survival in patients with high-grade glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Inflammation, a key event in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

New molecular targets in angiogenic vessels of glioblastoma tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Interleukin-6 gene amplification and shortened survival in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women's Heart and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Expression of tissue factor correlates with grade of malignancy in human glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Tissue factor, thrombin, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0290-X

Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.

21 January 2018

1 reference

12 December 2020

Soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) is decreased in lung cancer patients showing progression: a pilot study

1 reference

12 December 2020

Serum vascular endothelial growth factor is often elevated in disseminated cancer.

1 reference

12 December 2020

Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer

1 reference

12 December 2020

Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR

1 reference

12 December 2020

Gelation of fibrinogen in plasma. A kinetic study by turbidity measurement.

1 reference

12 December 2020

Clinical significance of preoperative serum sialic acid levels in colorectal cancer: utility in the detection of patients at high risk of tumor recurrence

1 reference

12 December 2020

Plasma fibronectin and sialic acid levels in various types of human brain tumors

1 reference

12 December 2020

Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.

1 reference

12 December 2020

Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma?

1 reference

12 December 2020

Predictive value of relative changes in serum total sialic acid level for response to neoadjuvant chemotherapy in patients with locally advanced breast carcinoma

1 reference

12 December 2020

Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer

1 reference

12 December 2020

Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.

1 reference

12 December 2020

MR imaging correlates of survival in patients with high-grade gliomas.

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression

1 reference

12 December 2020

Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients.

1 reference

12 December 2020

10.1007/S11060-010-0290-X

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018